« Previous
Next »
Fertility and Sterility
Volume 82, Issue 2
, Pages 322-326
, August 2004
Gonadotropin-releasing hormone agonist inhibits estrone sulfatase expression of cystic endometriosis in the ovary
References
- . On the aetiology of endometriosis. Acta Obstet Gynecol Scand. 1961;40:206–222
- . Estrogen biosynthesis in leiomyoma and myometrium of the uterus. Horm Metab Res. 1984;16:678–679
- . Estrogen synthesis in normal and malignant human endometrium. J Clin Endocrinol Metab. 1982;55:1029–1031
- . Evidence for estrogen synthesis in adenomyotic tissues. Am J Obstet Gynecol. 1993;169:734–738
- . Estrogen and progestin receptors in endometriosis lesions (comparison with endometrial tissue). Am J Obstet Gynecol. 1981;141:562–566
-
.
The role of estradiol, progesterone, and transforming growth factor on human endometrioma cell culture.
Am J Reprod Immunol. 1996;36:58–63
- . Aromatase expression in endometriosis. J Clin Endocrinol Metab. 1996;81:174–179
- . Metabolism of estrone sulfate in endometriotic tissue and in uterine endometrium in proliferative and secretory cycle phase. Fertil Steril. 1988;49:229–233
- . Importance of estrogen sulfates in breast cancer. J Steroid Biochem. 1989;34:155–163
- Enzymatic control of estrogen production in human breast cancer (relative significance of aromatase versus sulfatase pathways). Ann N Y Acad Sci. 1986;464:126–137
- . Plasma estrone sulfate (assessment of reduced estrogen production during treatment of metastatic breast carcinoma). Steroids. 1982;39:497–507
- Estrogen productivity of endometrium and endometrial cancer tissue (influence of aromatase on proliferation of endometrial cancer cells). J Steroid Biochem Mol Biol. 1993;44:463–468
- Estrone sulfate and sulfatase activity in human breast cancer and endometrial cancer. J Steroid Biochem. 1989;33:1049–1054
- . GnRH agonists and uterine leiomyomas. Hum Reprod. 1996;11(Suppl 3):3–25
- . GnRH agonists (an alternative to surgery?). Hum Reprod. 1996;11(Suppl 3):43–50
- . A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in case of uterine leiomyomas or endometriosis. J Obstet Gynaecol Res. 2000;26:325–331
- . Immunohistologic localization of estrone sulfatase in uterine endometrium and adenomyosis. Obstet Gynecol. 2001;98:815–819
-
Anti-estrone sulfatase monoclonal antibodies available for immunohistochemistry.
Acta Obstet Gynaecol Jpn. 1999;51(Suppl):362
- . Coexpression of cytokeratin and vimentin in eutopic endometrium and endometriosis throughout the menstrual cycle (evaluation by a computerized method). Fertil Steril. 1995;64:69–75
- . Estrogen receptor analysis (correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies). Arch Pathol Lab Med. 1985;109:716–721
- . Limited hormonal responsiveness of ectopic endometrium (histologic correlation with intrauterine endometrium). Hum Pathol. 1988;19:1417–1424
-
.
Action of GnRH agonist on gonadotrope physiology.
Semin Reprod Endocrinol. 1993;11:105–111
- Antitumoral effects of analogs of LH-RH and somatostatin (experimental and clinical studies). J Steroid Biochem Mol Biol. 1990;37:1061–1067
-
.
Treatment of uterine myomas with GnRH agonist.
Semin Reprod Endocrinol. 1993;11:154–161
- . Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. Obstet Gynecol. 1987;69:403–411
- . Primary and salvage therapy with LH-RH analogues in ovarian cancer. Recent Results Cancer Res. 2000;153:83–94
- . The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers. Hum Reprod. 1994;9:1364–1379
- . Detection and partial characterization of receptors for. [D-Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma Cancer Res. 1990;50:1841–1846
- . Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium. Gynecol Oncol. 1994;55:144–148
- . Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNA in various non-reproductive human tissues. Cancer Lett. 1995;98:57–62
-
.
Gonadotropin releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyoma and the direct action of GnRH-a on myometrial smooth muscle cells and interactions with ovarian steroids in vitro.
J Clin Endocrinol. 1996;81:3215–3221
- . Gene expression of gonadotropin releasing hormone, but not its receptor, in human endometrium and deciduas. Mol Cell Endocrinol. 1997;135:165–168
- . Expression of mRNA for luteinizing hormone-releasing hormone and its receptors and epidermal growth factor receptors in human cancer cell lines. Int J Oncol. 1998;12:671–675
- . Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature. 1985;313:231–233
- . Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP. J Clin Endocrinol Metab. 1992;75:207–212
- . High affinity binding and direct antiproliferative effects of LHRH analogues on human ovarian cancer cell lines. Cancer Res. 1993;53:5439–5446
- . High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines. J Clin Endocrinol Metab. 1993;77:1458–1464
- . Effects of GnRH-a on six ovarian cancer cell lines in culture. Gynecol Oncol. 1994;54:80–86
- Expression of GnRH receptor gene in human ectopic endometrial cells and inhibition of their proliferation by leuprolide acetate. Mol Cell Endocrinol. 2000;159:37–43
☆ Supported by Takeda Science Foundation, Japan.
PII: S0015-0282(04)00725-3
doi: 10.1016/j.fertnstert.2003.12.044
© 2004 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 82, Issue 2
, Pages 322-326
, August 2004

